The GoozNews blog notes the annual cost of new chemotherapeutic agents that received FDA approval during 2011 ranges from $44,000 to $216,000. Part of the problem, according to the pharmaceutical industry, is that FDA’s cautious approach in reviewing new drugs encourages companies to focus on therapeutic areas such as oncology where there is greater tolerance for risk.
